vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $340.0M, roughly 1.1× Walker & Dunlop, Inc.). AdvanSix Inc. runs the higher net margin — -0.8% vs -12.9%, a 12.1% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -0.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-680.1M). Over the past eight quarters, Walker & Dunlop, Inc.'s revenue compounded faster (22.1% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
ASIX vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $359.9M | $340.0M |
| Net Profit | $-2.8M | $-13.9M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | -17.2% |
| Net Margin | -0.8% | -12.9% |
| Revenue YoY | 9.4% | -0.4% |
| Net Profit YoY | -892.9% | -131.0% |
| EPS (diluted) | $-0.11 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $340.0M | ||
| Q3 25 | $374.5M | $337.7M | ||
| Q2 25 | $410.0M | $319.2M | ||
| Q1 25 | $377.8M | $237.4M | ||
| Q4 24 | $329.1M | $341.5M | ||
| Q3 24 | $398.2M | $292.3M | ||
| Q2 24 | $453.5M | $270.7M | ||
| Q1 24 | $336.8M | $228.1M |
| Q4 25 | $-2.8M | $-13.9M | ||
| Q3 25 | $-2.6M | $33.5M | ||
| Q2 25 | $31.4M | $34.0M | ||
| Q1 25 | $23.3M | $2.8M | ||
| Q4 24 | $352.0K | $44.8M | ||
| Q3 24 | $22.3M | $28.8M | ||
| Q2 24 | $38.9M | $22.7M | ||
| Q1 24 | $-17.4M | $11.9M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | -17.2% | ||
| Q3 25 | -0.9% | 13.6% | ||
| Q2 25 | 7.7% | 14.5% | ||
| Q1 25 | 7.7% | 2.2% | ||
| Q4 24 | -3.9% | 15.3% | ||
| Q3 24 | 7.5% | 12.8% | ||
| Q2 24 | 11.5% | 10.4% | ||
| Q1 24 | -7.0% | 6.0% |
| Q4 25 | -0.8% | -12.9% | ||
| Q3 25 | -0.7% | 9.9% | ||
| Q2 25 | 7.7% | 10.6% | ||
| Q1 25 | 6.2% | 1.2% | ||
| Q4 24 | 0.1% | 13.1% | ||
| Q3 24 | 5.6% | 9.9% | ||
| Q2 24 | 8.6% | 8.4% | ||
| Q1 24 | -5.2% | 5.2% |
| Q4 25 | $-0.11 | $-0.41 | ||
| Q3 25 | $-0.10 | $0.98 | ||
| Q2 25 | $1.15 | $0.99 | ||
| Q1 25 | $0.86 | $0.08 | ||
| Q4 24 | $0.02 | $1.32 | ||
| Q3 24 | $0.82 | $0.85 | ||
| Q2 24 | $1.43 | $0.67 | ||
| Q1 24 | $-0.65 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $299.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $1.7B |
| Total Assets | $1.7B | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $299.3M | ||
| Q3 25 | $23.7M | $274.8M | ||
| Q2 25 | $18.4M | $233.7M | ||
| Q1 25 | $8.3M | $181.0M | ||
| Q4 24 | $19.6M | $279.3M | ||
| Q3 24 | $17.3M | $179.8M | ||
| Q2 24 | $12.1M | $208.1M | ||
| Q1 24 | $20.6M | $216.5M |
| Q4 25 | $815.2M | $1.7B | ||
| Q3 25 | $818.2M | $1.8B | ||
| Q2 25 | $823.7M | $1.8B | ||
| Q1 25 | $794.4M | $1.7B | ||
| Q4 24 | $774.6M | $1.7B | ||
| Q3 24 | $766.4M | $1.7B | ||
| Q2 24 | $746.6M | $1.7B | ||
| Q1 24 | $713.2M | $1.7B |
| Q4 25 | $1.7B | $5.1B | ||
| Q3 25 | $1.7B | $5.8B | ||
| Q2 25 | $1.6B | $4.7B | ||
| Q1 25 | $1.6B | $4.5B | ||
| Q4 24 | $1.6B | $4.4B | ||
| Q3 24 | $1.5B | $4.6B | ||
| Q2 24 | $1.5B | $4.2B | ||
| Q1 24 | $1.5B | $3.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $-664.3M |
| Free Cash FlowOCF − Capex | $36.1M | $-680.1M |
| FCF MarginFCF / Revenue | 10.0% | -200.0% |
| Capex IntensityCapex / Revenue | 7.7% | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $-664.3M | ||
| Q3 25 | $26.6M | $-948.1M | ||
| Q2 25 | $21.1M | $-238.5M | ||
| Q1 25 | $11.4M | $-281.1M | ||
| Q4 24 | $64.2M | $129.4M | ||
| Q3 24 | $57.3M | $-202.0M | ||
| Q2 24 | $50.2M | $-237.8M | ||
| Q1 24 | $-36.2M | $38.4M |
| Q4 25 | $36.1M | $-680.1M | ||
| Q3 25 | $66.0K | $-950.4M | ||
| Q2 25 | $-7.2M | $-241.0M | ||
| Q1 25 | $-22.6M | $-284.7M | ||
| Q4 24 | $29.8M | $116.4M | ||
| Q3 24 | $26.8M | $-204.0M | ||
| Q2 24 | $16.7M | $-241.7M | ||
| Q1 24 | $-71.6M | $35.2M |
| Q4 25 | 10.0% | -200.0% | ||
| Q3 25 | 0.0% | -281.5% | ||
| Q2 25 | -1.7% | -75.5% | ||
| Q1 25 | -6.0% | -120.0% | ||
| Q4 24 | 9.1% | 34.1% | ||
| Q3 24 | 6.7% | -69.8% | ||
| Q2 24 | 3.7% | -89.3% | ||
| Q1 24 | -21.3% | 15.4% |
| Q4 25 | 7.7% | 4.6% | ||
| Q3 25 | 7.1% | 0.7% | ||
| Q2 25 | 6.9% | 0.8% | ||
| Q1 25 | 9.0% | 1.5% | ||
| Q4 24 | 10.4% | 3.8% | ||
| Q3 24 | 7.7% | 0.7% | ||
| Q2 24 | 7.4% | 1.4% | ||
| Q1 24 | 10.5% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | -28.34× | ||
| Q2 25 | 0.67× | -7.02× | ||
| Q1 25 | 0.49× | -102.07× | ||
| Q4 24 | 182.29× | 2.89× | ||
| Q3 24 | 2.57× | -7.01× | ||
| Q2 24 | 1.29× | -10.49× | ||
| Q1 24 | — | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
WD
Segment breakdown not available.